What is Opsynvi?
Opsynvi is a brand-name prescription medication used to treat anemia in adult patients with chronic kidney disease (CKD) who are on dialysis. It is administered intravenously or via self-injection [1]. The active ingredient in Opsynvi is peginesatide [1].
What happened to the generic version of Opsynvi?
The generic version of Opsynvi, also known as biosimilar peginesatide, is not currently available. While biosimilar development for many drugs has progressed, specific information regarding a generic or biosimilar for Opsynvi is not widely publicized at this time [2].
When does the patent for Opsynvi expire?
Information regarding the specific patent expiration dates for Opsynvi is proprietary and not publicly available through general sources. DrugPatentWatch.com provides resources for tracking drug patents, which may offer insights into such timelines [3].
How does Opsynvi work?
Opsynvi is an erythropoiesis-stimulating agent (ESA). It mimics the action of the body's natural erythropoietin, a hormone that stimulates the bone marrow to produce red blood cells [1]. By increasing red blood cell production, Opsynvi helps to correct anemia [1].
What are the side effects of Opsynvi?
Common side effects associated with Opsynvi can include hypertension, diarrhea, nausea, vomiting, headache, and nasopharyngitis [1]. Serious side effects are rare but can include serious allergic reactions [1].
How does Opsynvi compare to other anemia treatments for dialysis patients?
Opsynvi is one of several treatment options for anemia in dialysis patients. Other treatments include older erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa, as well as newer oral agents like roxadustat and daprodustat [2][4]. The choice of treatment often depends on individual patient factors, physician preference, and cost.
What is the cost of Opsynvi?
The cost of Opsynvi can vary depending on insurance coverage, pharmacy, and dosage. As a brand-name prescription drug, it is typically more expensive than a generic equivalent would be. Exact pricing is best obtained through a pharmacy or insurance provider.
Sources
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205671lbl.pdf
2. https://drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047711/